C9orf72 and amyotrophic lateral sclerosis: The study was designed to compare ALS patients carrying the C9ORF72 repeat expansion with ALS patients who tested negative for the expansion, with the aim to highlight a proteomics signature associated with the presence of this mutation and possibly unveil C9ORF72-related pathogenetic mechanisms in ALS.